Patent 7101877 was granted and assigned to Cardiome Pharma on September, 2006 by the United States Patent and Trademark Office.
Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.